APA

Xu H., Chen T., Wang W., Wu C., Liu C., Long J., Xu J., Zhang Y., Chen R., Liu L. & Yu X. (20150209). Metabolic tumour burden assessed by ¹⁸F-FDG PET/CT associated with serum CA19-9 predicts pancreatic cancer outcome after resection. : European journal of nuclear medicine and molecular imaging.

Chicago

Xu Hua-Xiang, Chen Tao, Wang Wen-Quan, Wu Chun-Tao, Liu Chen, Long Jiang, Xu Jin, Zhang Ying-Jian, Chen Run-Hao, Liu Liang and Yu Xian-Jun. 20150209. Metabolic tumour burden assessed by ¹⁸F-FDG PET/CT associated with serum CA19-9 predicts pancreatic cancer outcome after resection. : European journal of nuclear medicine and molecular imaging.

Harvard

Xu H., Chen T., Wang W., Wu C., Liu C., Long J., Xu J., Zhang Y., Chen R., Liu L. and Yu X. (20150209). Metabolic tumour burden assessed by ¹⁸F-FDG PET/CT associated with serum CA19-9 predicts pancreatic cancer outcome after resection. : European journal of nuclear medicine and molecular imaging.

MLA

Xu Hua-Xiang, Chen Tao, Wang Wen-Quan, Wu Chun-Tao, Liu Chen, Long Jiang, Xu Jin, Zhang Ying-Jian, Chen Run-Hao, Liu Liang and Yu Xian-Jun. Metabolic tumour burden assessed by ¹⁸F-FDG PET/CT associated with serum CA19-9 predicts pancreatic cancer outcome after resection. : European journal of nuclear medicine and molecular imaging. 20150209.